GNA Biosolutions' Series A Round

GNA Biosolutions raised a round of funding on December 20, 2012. Investors include Mey Capital Matrix.

GNA Biosolutions develops instruments, OEM modules, and assays for ultra-fast, molecular pathogen detection thanks to its breakthrough technology: Laser PCR, ultra-fast laser heating of nanoparticles,…

Articles about GNA Biosolutions' Series A Round: